Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A tumor-responsive p53-loaded nanovesicle system for senescence induction and immune microenvironment reprogramming.

Created on 11 Nov 2026

Authors

Zhaoming Guo, Yuwei Gong, Jinxuan Chen, Lanjun Shen, Wenzhe Wang, Qing Qi, Yueyun Chi, Kun Ma, Hao Ju, Yanshuo Han

Published in

International journal of pharmaceutics. Pages 127625. Nov 10, 2026. Epub Nov 10, 2026.

Abstract

The tumor immune microenvironment (TIME) critically regulates the balance between antitumor immunity and immune evasion. Although cellular senescence can promote immune-mediated tumor clearance through the senescence-associated secretory phenotype (SASP), this mechanism is frequently compromised by loss of p53 function, particularly in triple-negative breast cancer (TNBC). Consequently, strategies capable of restoring p53 activity while harnessing intact immune-responsive pathways are urgently needed. Integrated transcriptomic analyses provided a computational basis for this therapeutic strategy. Bulk RNA-seq demonstrated that, in TNBC, the downstream SASP-immune activation axis remains largely preserved, whereas the upstream p53-SASP coupling is disrupted, supporting the concept that exogenous p53 restoration may effectively re-engage immune programs. Single-cell RNA-seq further revealed that p53-functional malignant cells exhibit enhanced tumor-immune communication and immune-recognition signals, reinforcing the feasibility of p53 reactivation to remodel the TIME. Guided by these insights, we engineered a dual-functional, tumor-responsive nanovesicle system for p53 delivery. Escherichia coli was genetically modified to express p53, and p53-loaded outer membrane vesicles (OMV@p53) were coated with a biomimetic calcium phosphate shell via bionanomorphic mineralization, yielding acid-responsive nanovesicles (Ca@OMV@p53; 200-300 nm). This coating enhanced biocompatibility and enabled pH-triggered release within the mildly acidic tumor microenvironment. In vitro, Ca@OMV@p53 efficiently induced tumor cell senescence and promoted M1 macrophage polarization. In vivo, treatment markedly increased intratumoral infiltration of M1 macrophages and cytotoxic T lymphocytes, accompanied by elevated pro-inflammatory cytokines and sustained immune activation. Together, this study demonstrates that p53-restoration via a tumor-responsive nanodelivery system can synergistically induce senescence and immune-mediated tumor clearance. By integrating systems-level bioinformatics with experimental nanomedicine, our work establishes a rational framework for senescence-based immunomodulatory cancer therapy.

PMID:
43008957
Bibliographic data and abstract were imported from PubMed on 11 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement